Zobrazeno 1 - 9
of 9
pro vyhledávání: '"T. G. Samartseva"'
Autor:
A. S. Oksanich, T. G. Samartseva, K. V. Kaa, E. V. Otrashevskaia, A. G. Krasko, A. G. Laputina, N. A. Netesova, G. M. Ignatyev
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 24, Iss 3, Pp 279-293 (2024)
INTRODUCTION. The completeness of virus inactivation and the identity of the vaccine strain are essential parameters for the safety and quality of inactivated virus vaccines, which should be controlled during vaccine development and production. Curre
Externí odkaz:
https://doaj.org/article/e4af3004a74a412b94cb3db07b5803cc
Autor:
N. A. Netesova, M. A. Abdurashitov, T. G. Samartseva, O. V. Klimovich, A. S. Oksanich, Е. V. Otrashevskaia, G. M. Ignatyev
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 24, Iss 3, Pp 270-278 (2024)
INTRODUCTION. Chikungunya virus (CHIKV) genotyping involves sequencing fractions of genes encoding E1, E2, and nsP1 proteins or the entire genome of the virus. Available reagent kits or polymerase chain reaction protocols cannot be used for CHIKV gen
Externí odkaz:
https://doaj.org/article/05fbe65f3d8846618b67160f30103918
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 23, Iss 4, Pp 544-559 (2023)
Scientific relevance. To date, no specific antivirals have been approved to treat and prevent Chikungunya fever, its complications, and sequelae. Therefore, the development of therapeutic and preventive medicinal products against Chikungunya virus (C
Externí odkaz:
https://doaj.org/article/cdde65c2928e4e5f922ab153eac6eb68
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 22, Iss 4, Pp 405-413 (2022)
The severe consequences and high mortality of COVID-19 prompted the development of a wide range of preventive vaccines. The first vaccines to be tested were developed in China and formulated as inactivated SARS-CoV-2 adsorbed on aluminium hydroxide.
Externí odkaz:
https://doaj.org/article/46a8a117529a47f89b63ddcade4d2c17
Autor:
G. M. Ignatyev, A. S. Oksanich, L. P. Antonova, T. G. Samartseva, S. V. Mosolova, K. M. Mefed, l. V. Gmyl, N. A. Netesova
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 20, Iss 2, Pp 107-115 (2020)
Rabies is an acute viral disease caused by a virus of the Rhabdoviridae family of the Lyssavirus genus, which affects the central nervous system and is characterised by absolute mortality. Vaccination is the only way to prevent the disease in humans.
Externí odkaz:
https://doaj.org/article/5a45e23d9a974b9e8d8fcf230bd11a20
Autor:
T. G. Samartseva, A. S. Oksanich, N. F. Gavrilova, I. V. Yakovleva, V. V. Sviridov, V. V. Zverev
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 1, Iss 3, Pp 32-39 (2019)
Aim. In this study we aimed to develop the methodology to change the antigen specificity of chimeric antibodies by replacing the variable region genes in the previously designed universal plasmid constructions pLK DT-17 and pHG DT-17 encoding the DT-
Externí odkaz:
https://doaj.org/article/668e8c9995fc4536ab0a5e5acfa0b535
Autor:
A. A. Kushch, R. R. Klimova, N. E. Fedorova, O. V. Masalova, A. A. Niconova, E. I. Lesnova, E. D. Momotyuk, N. A. Demidova, T. G. Samartseva, V. V. Zverev
Publikováno v:
Вопросы вирусологии, Vol 64, Iss 2, Pp 90-96 (2019)
Introduction. Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infections in infants and the elderly. The absence of a wide range of therapeutic drugs and vaccines indicates to the high relevance of the developmen
Externí odkaz:
https://doaj.org/article/948580eece72423682e402110c4c4aa5
Autor:
A. S. Oksanich, T. G. Samartseva, E. B. Faizjuloev, N. F. Gavrilova, I. V. Yakovleva, V. V. Sviridov, V. V. Zverev
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 0, Iss 6, Pp 56-63 (2017)
Aim. In this study we aimed to design the universal genetic construction expressing the light and heavy chains of a chimeric antibody, to develop methodological approaches for the production of chimeric antibodies with defined specificity using the m
Externí odkaz:
https://doaj.org/article/dcd5d66bf4ca41d983aed04e590bf7e9
Autor:
Klimova Rr, T G Samartseva, N A Demidova, Alla A. Kushch, N E Fedorova, O. V. Masalova, E. D. Momotyuk, A A Niconova, E. I. Lesnova, Zverev Vv
Publikováno v:
Problems of Virology. 64:90-96
Introduction. Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infections in infants and the elderly. The absence of a wide range of therapeutic drugs and vaccines indicates to the high relevance of the developmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c11109f3a721b611d1a5257b2085f8e
https://doi.org/10.18821/0507-4088-2019-64-2-90-96
https://doi.org/10.18821/0507-4088-2019-64-2-90-96